The Journal of Thoracic and Cardiovascular Surgery
Volume 128, Issue 4 , Pages 643-645 , October 2004

Use of the AbioCor replacement heart as destination therapy for end-stage heart failure with irreversible pulmonary hypertension

  • Louis Samuels, MD

      Affiliations

    • Lankenau Hospital, Department of Cardiothoracic Surgery, Wynnewood, Pennsylvania, USA
    • Corresponding Author InformationAddress for reprints: Louis E. Samuels, MD, Lankenau Hospital, Department of Cardiothoracic Surgery, MSB Suite 280, 100 Lancaster Avenue, Wynnewood, PA 19096, USA
  • ,
  • John Entwistle, MD

      Affiliations

    • Drexel University, Hahnemann University Hospital, Department of Cardiothoracic Surgery, Philadelphia, Pennsylvania, USA
  • ,
  • Elena Holmes, CRNP

      Affiliations

    • Lankenau Hospital, Department of Cardiothoracic Surgery, Wynnewood, Pennsylvania, USA
  • ,
  • Jane Fitzpatrick, MD

      Affiliations

    • Drexel University, Hahnemann University Hospital, Department of Cardiothoracic Surgery, Philadelphia, Pennsylvania, USA
  • ,
  • Andrew Wechsler, MD

      Affiliations

    • Drexel University, Hahnemann University Hospital, Department of Cardiothoracic Surgery, Philadelphia, Pennsylvania, USA

Received 24 July 2003 ,Accepted 31 March 2004.

References 

  1. Cimato TR, Jessup M. Recipient selection in cardiac transplantation (contraindications and risk factors for mortality). J Heart Lung Transplant. 2002;21:1161–1173 Review
  2. Dowling RD, Gray LA, Etoch SW, Laks H, Marelli D, Samuels L, et al.  The AbioCor implantable replacement heart. Ann Thorac Surg. 2003;75(6 Suppl):S93–99
  3. Samuels LE, Dowling R. Total artificial heart (destination therapy). Cardiol Clin. 2003;21:115–118
  4. Kukuy EL, Oz MC, Rose EA, Naka Y. Devices as destination therapy. Cardiol Clin. 2003;21:67–73

PII: S0022-5223(04)00654-3

doi: 10.1016/j.jtcvs.2004.03.052

The Journal of Thoracic and Cardiovascular Surgery
Volume 128, Issue 4 , Pages 643-645 , October 2004